In an interview to CNBC-TV18, Uday Baldota of Sun Pharma says the results of Taro, have been boosted by lack of competition and Forex gains. With 'very strong numbers' reported by Taro this quarter, Badola says its delisting process is still ongoing.
first published: Nov 14, 2011 02:29 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty recovers 100 pts from day's low, metals under pressure | Closing Bell

Govt to stick to the path of fiscal consolidation - Prof Dev, PMEC chairman

Budget 2026 expectations: Taxpayers eye higher standard deduction, home loan interest relief

Live: Will Nifty take a breather after 3-day rally amid mixed global cues | Opening Bell
You are already a Moneycontrol Pro user.